title: Organotypic brain slices: a model to study the neurovascular unit micro-environment in epilepsies.
abstract: BACKGROUND
  It is now recognized that the neuro-vascular unit (NVU) plays a key role in several neurological diseases including epilepsy, stroke, Alzheimer's disease, multiple sclerosis and the development of gliomas. Most of these disorders are associated with NVU dysfunction, due to overexpression of inflammatory factors such as vascular endothelial growth factor (VEGF). Various in vitro models have been developed previously to study the micro-environment of the blood-brain barrier (BBB). However none of these in vitro models contained a complete complement of NVU cells, nor maintained their interactions, thus minimizing the influence of the surrounding tissue on the BBB development and function. The organotypic hippocampal culture (OHC) is an integrative in vitro model that allows repeated manipulations over time to further understand the development of cell circuits or the mechanisms of brain diseases.
  
  
  METHODS
  OHCs were cultured from hippocampi of 6-7 day-old Sprague Dawley rats. After 2 weeks in culture, seizures were induced by application of kainate or bicuculline into culture medium. The regulation of BBB integrity under physiological and pathological conditions was evaluated by immunostaining of the main tight junction (TJ) proteins and of the basal membrane of microvessels. To mimic or prevent BBB disassembly, we used diverse pro- or anti-angiogenic treatments.
  
  
  CONCLUSIONS
  This study demonstrates that NVU regulation can be investigated using OHCs. We observed in this model system an increase in vascularization and a down-regulation of TJ proteins, similar to the vascular changes described in a chronic focus of epileptic patients, and in rodent models of epilepsy or inflammation. We observed that Zonula occludens-1 (ZO-1) protein disappeared after seizures associated with neuronal damage. In these conditions, the angiopoeitin-1 system was down-regulated, and the application of r-angiopoeitin-1 allowed TJ re-assembly. This article demonstrates that organotypic culture is a useful model to decipher the links between epileptic activity and vascular damage, and also to investigate NVU regulation in diverse neurological disorders.
authors: Institut de Génomique Fonctionnelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, 2, Montpellier, France. mireille.lerner-natoli@igf.cnrs.fr.
authors: Mélanie
authors: M
authors: Morin-Brureau
authors: Frédéric
authors: F
authors: De Bock
authors: Mireille
authors: M
authors: Lerner-Natoli
references: Comput Biol Med. 1985;15(3):153-8
references: 3891214
references: J Mol Neurosci. 2011 Jun;44(2):130-9
references: 21318404
references: J Neurosci Methods. 1981 Dec;4(4):329-42
references: 7033675
references: J Comp Neurol. 2001 Mar 5;431(2):217-27
references: 11170001
references: Neurobiol Dis. 2010 Jan;37(1):26-32
references: 19664708
references: J Neurosci Methods. 2011 Aug 15;199(2):223-9
references: 21609734
references: Methods Mol Biol. 2011;686:49-68
references: 21082366
references: Exp Cell Res. 2011 Mar 10;317(5):685-90
references: 21040721
references: J Neurosci. 2011 Jul 20;31(29):10677-88
references: 21775611
references: FASEB J. 2004 Jan;18(1):161-3
references: 14597552
references: Neurobiol Dis. 2010 Jan;37(1):13-25
references: 19664713
references: J Immunol. 1999 Aug 15;163(4):2151-9
references: 10438956
references: J Anat. 2002 Jun;200(6):629-38
references: 12162730
references: Toxicol In Vitro. 2009 Apr;23(3):447-53
references: 19135142
references: Biochim Biophys Acta. 2011 May;1813(5):878-88
references: 21296109
references: Stroke. 2005 Jul;36(7):1533-7
references: 15947259
references: Cell Tissue Res. 2009 Jan;335(1):75-96
references: 18633647
references: Adv Immunol. 2007;96:41-101
references: 17981204
references: Crit Rev Immunol. 2009;29(1):43-68
references: 19348610
references: Life Sci. 1997;60(17):PL 251-6
references: 9126873
references: Cell Tissue Res. 2004 Feb;315(2):157-66
references: 14615934
references: Annu Rev Immunol. 2004;22:929-79
references: 15032600
references: J Microbiol Biotechnol. 2008 Feb;18(2):377-82
references: 18309287
references: J Neurochem. 2004 Aug;90(3):526-36
references: 15255930
references: Brain Res. 2002 Sep 20;950(1-2):103-18
references: 12231234
references: Stroke. 2008 Sep;39(9):2560-70
references: 18635850
references: J Clin Invest. 2012 Jul;122(7):2454-68
references: 22653056
references: Lab Invest. 2005 Oct;85(10):1189-98
references: 16056241
references: Am J Physiol. 1992 Jul;263(1 Pt 1):C1-16
references: 1636671
references: Nature. 2011 May 19;473(7347):298-307
references: 21593862
references: Eur J Neurosci. 1998 Oct;10(10):3107-14
references: 9786205
references: J Neurosci Methods. 1991 Apr;37(2):173-82
references: 1715499
references: Nature. 1997 Jun 5;387(6633):611-7
references: 9177350
references: Brain Res. 2011 Jan 31;1371:110-20
references: 21111720
references: Nat Rev Neurosci. 2011 Nov 03;12(12):723-38
references: 22048062
references: Epilepsia. 2011 Oct;52 Suppl 8:19-20
references: 21967353
references: Brain. 2007 Jul;130(Pt 7):1942-56
references: 17533168
references: Nat Rev Neurosci. 2006 Jan;7(1):41-53
references: 16371949
references: Microcirculation. 2003 Dec;10(6):463-70
references: 14745459
references: Neurochem Res. 2009 Dec;34(12):2067-77
references: 19856206
references: J Cereb Blood Flow Metab. 2011 Feb;31(2):767-77
references: 20842162
references: Curr Med Chem. 2010;17(10):987-1001
references: 20156165
references: Neuropharmacology. 2011 Jun;60(7-8):1116-25
references: 20932983
references: Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):2005-9
references: 22302624
references: Adv Virus Res. 2011;79:73-89
references: 21601043
references: Neurobiol Dis. 2006 Dec;24(3):429-42
references: 17027274
references: Proc Natl Acad Sci U S A. 1989 Jan;86(2):612-6
references: 2643119
references: Nat Med. 2010 Dec;16(12):1370-1
references: 21135839
references: J Immunol Methods. 2003 Feb;273(1-2):83-101
references: 12535800
references: J Neuroimmunol. 2010 Dec 15;229(1-2):180-91
references: 20832870
references: J Pharm Sci. 2012 Apr;101(4):1337-54
references: 22213383
references: Drug Discov Today. 2005 Jul 15;10(14):993-1000
references: 16023058
references: J Cereb Blood Flow Metab. 2011 Feb;31(2):693-705
references: 20827262
references: Acta Neurobiol Exp (Wars). 2011;71(1):113-28
references: 21499332
references: Neurobiol Dis. 2009 Apr;34(1):121-32
references: 19320047
references: J Immunol. 1997 Feb 1;158(3):1033-6
references: 9013939
references: J Biol Chem. 1996 Aug 23;271(34):20545-50
references: 8702798
references: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2645-50
references: 12598651
references: J Neurooncol. 1991 Aug;11(1):49-55
references: 1919646
references: Int J Cancer. 2003 Jun 20;105(3):340-6
references: 12704667
references: Brain. 2007 Feb;130(Pt 2):521-34
references: 17124188
references: J Mol Neurosci. 2012 Jan;46(1):236-47
references: 21710361
references: Biochem Biophys Res Commun. 1997 Oct 29;239(3):804-9
references: 9367850
references: PLoS One. 2012;7(7):e40535
references: 22808185
references: Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):3-8
references: 15720228
references: J Cereb Blood Flow Metab. 2011 Dec;31(12):2343-51
references: 21772310
references: Cardiovasc Psychiatry Neurol. 2011;2011:765923
references: 21436875
references: Brain Res Bull. 2005 Mar 15;65(2):125-31
references: 15763178
references: Glia. 2005 Aug 15;51(3):187-98
references: 15800928
references: J Neuroimmunol. 1996 Jan;64(1):37-43
references: 8598388
references: Neurosurg Rev. 2011 Jul;34(3):253-63; discussion 263-4
references: 21656131
references: Trends Neurosci. 1997 Oct;20(10):471-7
references: 9347615
references: PLoS One. 2011;6(8):e23789
references: 21909359
references: Circ Res. 2008 Oct 10;103(8):784-95
references: 18845818
references: Cardiovasc Psychiatry Neurol. 2011;2011:646958
references: 21350722
references: J Neurosci. 2007 Mar 21;27(12):3260-7
references: 17376986
references: Methods Mol Biol. 2007;399:55-66
references: 18309925